BRAF and melanoma: Therefore, in order to evaluate the value of PLA1A expression as a diagnostic marker in the treatment of BRAF/NRAS-mutant melanoma, the expression of PLA1A in BRAF and NRAS mutant samples was evaluated through the use of the linear logistic regression in Fig. 2D,E, respectively.